TRPV1 in brain is involved in acetaminophen-induced antinociception

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-11

  Mallet, Christophe ^a,b   Barrière, David A ^a,b   Ermund, Anna ^c   Jönsson, Bo A G ^c   Eschalier, Alain ^a,b   Zygmunt, Peter M ^c   Högestätt, Edward D ^c  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b INSERM   (France)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAZEPINE; ENDOCANNABINOID; FATTY ACID AMIDASE; FORMALDEHYDE; IBUPROFEN; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; PARACETAMOL; PROSTAGLANDIN E2; VANILLOID RECEPTOR 1; ANALGESIC AGENT; TRPV1 PROTEIN, MOUSE; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG DOSAGE FORM COMPARISON; DRUG STRUCTURE; ENZYME INHIBITION; FEMALE; IMMERSION; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; RAT; STRUCTURE ANALYSIS; TAIL; ANIMAL; BRAIN; C57BL MOUSE; DRUG EFFECT; METABOLISM; SPRAGUE DAWLEY RAT;

MUS; RATTUS;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; BRAIN; ENDOCANNABINOIDS; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY; TRPV CATION CHANNELS;

EID: 77958557341     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012748     Document Type: Article

References (54)

1. Brodie BB, Axelrod J (1948) The fate of acetanilide in man. J Pharmacol Exp Ther 94: 29-38.
2. Ong CK, Seymour RA, Lirk P, Merry AF (2010) Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg 110: 1170-1179.
3. Hunskaar S, Hole K (1987) The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30: 103-114.
4. Ballou LR, Botting RM, Goorha S, Zhang J, Vane JR (2000) Nociception in cyclooxygenase isozyme-deficient mice. Proc Natl Acad Sci U S A 97: 10272-10276.
5. Bujalska M, Gumulka WS (2001) Effect of cyclooxygenase and NO synthase inhibitors on antinociceptive action of acetaminophen. Pol J Pharmacol 53: 341-350.
6. Mallet C, Daulhac L, Bonnefont J, Ledent C, Etienne M, et al. (2008) Endocannabinoid and serotonergic systems are needed for acetaminopheninduced analgesia. Pain 139: 190-200.
7. Ayoub SS, Colville-Nash PR, Willoughby DA, Botting RM (2006) The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice. Eur J Pharmacol 538: 57-65.
8. Pini LA, Sandrini M, Vitale G (1996) The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain. Eur J Pharmacol 308: 31-40.
9. Björkman R (1995) Central antinociceptive effects of non-steroidal antiinflammatory drugs and paracetamol. Acta Anaesthesiol Scand 39(suppl 103): 1-44.
10. Choi S-S, Lee J-K, Suh H-W (2001) Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models. Brain Res 921: 233-239.
11. Piletta P, Porchet H, Drayer P (1991) Central analgesic effect of acetaminophen but not of aspirin. Clin Pharmacol Ther 49: 350-354.
12. Högestätt ED, Jönsson BAG, Ermund A, Andersson DA, Björk H, et al. (2005) Conversion of acetaminophen to the bioactive N-acyl phenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem 280: 31405-31412.
13. Costa B, Siniscalco D, Trovato AE, Comelli F, Sotgiu ML, et al. (2006) AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain. Br J Pharmacol 148: 1022-1032.
14. Borsani E, Labanca M, Bianchi R, Rodella LF (2007) AM404 decreases Fosimmunoreactivity in the spinal cord in a model of inflammatory pain. Brain Res 1152: 87-94.
15. Guhring H, Hamza M, Sergejeva M, Ates M, Kotalla CE, et al. (2002) A role for endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol 454: 153-163.
16. Ruggieri V, Vitale G, Pini LA, Sandrini M (2008) Differential involvement of opioidergic and serotonergic systems in the antinociceptive activity of Narachidonoyl- phenolamine (AM404) in the rat: comparison with paracetamol. Naunyn Schmiedebergs Arch Pharmacol 377: 219-229.
17. Hasanein P, Soltani N (2009) Effects of the endocannabinoid transport inhibitors AM404 and UCM707 on diabetic neuropathy in rats. Clin Exp Pharmacol Physiol 36: 1127-1131.
18. Palazzo E, de Novellis V, Petrosino S, Marabese I, Vita D, et al. (2006) Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system. Eur J Neurosci 24: 2011-2020.
19. La Rana G, Russo R, Campolongo P, Bortolato M, Mangieri RA, et al. (2006) Modulation of Neuropathic and Inflammatory Pain by the Endocannabinoid Transport Inhibitor AM404 [N-(4-Hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]. J Pharmacol Exp Ther 317: 1365-1371.
20. Mitchell VA, Greenwood R, Jayamanne A, Vaughan CW (2007) Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models. Clin Exp Pharmacol Physiol 34: 1186-1190.
21. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, et al. (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277: 1094-1097.
22. Zygmunt PM, Chuang H, Movahed P, Julius D, Högestätt ED (2000) The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol 396: 39-42.
23. De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V (2000) Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett 483: 52-56.
24. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, et al. (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288: 306-313.
25. Bolcskei K, Helyes Z, Szabo A, Sandor K, Elekes K, et al. (2005) Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice. Pain 117: 368-376.
26. Fegley D, Kathuria S, Mercier R, Li C, Goutopoulos A, et al. (2004) Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc Natl Acad Sci US A 101: 8756-8761.
27. Björkman R, Hallman KM, Hedner J, Hedner T, Henning M (1994) Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain 57: 259-264.
28. Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, et al. (2006) Elevation of Endocannabinoid Levels in the Ventrolateral Periaqueductal Grey through Inhibition of Fatty Acid Amide Hydrolase Affects Descending Nociceptive Pathways via Both Cannabinoid Receptor Type 1 and Transient Receptor Potential Vanilloid Type-1 Receptors. J Pharmacol Exp Ther 316: 969-982.
29. Palazzo E, de Novellis V, Marabese I, Cuomo D, Rossi F, et al. (2002) Interaction between vanilloid and glutamate receptors in the central modulation of nociception. Eur J Pharmacol 439: 69-75.
30. Toth A, Boczan J, Kedei N, Lizanecz E, Bagi Z, et al. (2005) Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res Mol Brain Res 135: 162-168.
31. Pelissier T, Alloui A, Caussade F, Dubray C, Cloarec A, et al. (1996) Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence. J Pharmacol Exp Ther 278: 8-14.
32. Pickering G, Loriot M-A, Libert F, Eschalier A, Beaune P, et al. (2006) Analgesic effect of acetaminophen in humans: First evidence of a central serotonergic mechanism. Clin Pharmacol Ther 79: 371-378.
33. Alloui A, Pelissier T, Dubray C, Lavarenne J, Eschalier A (1996) Tropisetron inhibits the antinociceptive effect of intrathecally administered paracetamol and serotonin. Fundam Clin Pharmacol 10: 406-407.
34. Alloui A, Chassaing C, Schmidt J, Ardid D, Dubray C, et al. (2002) Paracetamol exerts a spinal, tropisetron-reversible, antinociceptive effect in an inflammatory pain model in rats. Eur J Parmacol 443: 71-77.
35. Bonnefont J, Chapuy E, Clottes E, Alloui A, Eschalier A (2005) Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain 114: 482-490.
36. Starowicz K, Maione S, Cristino L, Palazzo E, Marabese I, et al. (2007) Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways. J Neurosci 27: 13739-13749.
37. Lever IJ, Robinson M, Cibelli M, Paule C, Santha P, et al. (2009) Localization of the endocannabinoid-degrading enzyme fatty acid amide hydrolase in rat dorsal root ganglion cells and its regulation after peripheral nerve injury. J Neurosci 29: 3766-3780.
38. Tsou K, Nogueron MI, Muthian S, Sanudo-Pena MC, Hillard CJ, et al. (1998) Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci Lett 254: 137-140.
39. Ottani A, Leone S, Sandrini M, Ferrari A, Bertolini A (2006) The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. Eur J Parmacol 531: 280-281.
40. Fowler CJ, Stenstrom A, Tiger G (1997) Ibuprofen inhibits the metabolism of the endogenous cannabimimetic agent anandamide. Pharmacol Toxicol 80: 103-107.
41. Khanolkar AD, Abadji V, Lin S, Hill WAG, Taha G, et al. (1996) Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand. J Med Chem 39: 4515-4519.
42. Fioravanti B, De Felice M, Stucky CL, Medler KA, Luo MC, et al. (2008) Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists. J Neurosci 28: 11593-11602.
43. Hermann H, De Petrocellis L, Bisogno T, Schiano Moriello A, Lutz B, et al. (2003) Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. Cell Mol Life Sci 60: 607-616.
44. Flower RJ, Vane JR (1972) Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 240: 410-411.
45. McPartland JM (2004) Phylogenomic and chemotaxonomic analysis of the endocannabinoid system. Brain Res Brain Res Rev 45: 18-29.
46. Glaser ST, Kaczocha M (2009) Temporal changes in mouse brain fatty acid amide hydrolase activity. Neuroscience 163: 594-600.
47. Knotkova H, Pappagallo M, Szallasi A (2008) Capsaicin (TRPV1 Agonist) Therapy for Pain Relief: Farewell or Revival? Clin J Pain 24: 142-154.
48. Patapoutian A, Tate S, Woolf CJ (2009) Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov 8: 55-68.
49. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, et al. (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 98: 9371-9376.
50. Seal RP, Wang X, Guan Y, Raja SN, Woodbury CJ, et al. (2009) Injury-induced mechanical hypersensitivity requires C-low threshold mechanoreceptors. Nature 462: 651-655.
51. Rouzer CA, Ghebreselasie K, Marnett LJ (2002) Chemical stability of 2- arachidonylglycerol under biological conditions. Chem Phys Lipids 119: 69-82.
52. Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-778.
53. Jordt SE, Julius D (2002) Molecular basis for species-specific sensitivity to "hot" chili peppers. Cell 108: 421-430.
54. Jung J, Hwang SW, Kwak J, Lee SY, Kang CJ, et al. (1999) Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci 19: 529-538.